| THURSDAY, OCTOBER 1, 2020. |
| 08:30-17:00 |
Registration of participants |
|
| 1.CARDIOMYOPATHIES-AMYLOIDOSIS: IMPORTANCE OF NUCLEAR MEDICINE |
|
Chairpersons: Arsen Ristić, Dragana Šobić Šaranović
|
| 09:00-09:15 |
Arsen Ristić, Belgrade |
Amyloidosis – cardiologist view |
| 09:15-09:30 |
Sophia Koukouraki, Heraklion |
Planar and hybrid SPECT/CT cardiac imaging in the assessment of cardiac transthyretin amyloidosis – Crete experience |
| 09:30-09:45 |
Ružica Maksimović, Belgrade |
MRI in cardiac amyloidosis |
| 09:45-10:00 |
Venjamin Majstorov, Skopje |
Cardiac imaging in the assessment of cardiac transthyretin amyloidosis – North Macedonia experience |
| 10:00-10:15 |
Dragana Sobic Saranovic, Belgrade |
Whole body DPD scintigraphy in cardiac transthyretin amyloidosis – experience of Center of Nuclear Medicine CCS |
| 10:15-10:25 |
Discussion |
|
| 2. ARTIFICIAL INTELLIGENCE IN CARDIOVASCULAR MEDICINE |
|
Chairpersons: Marcus Hacker, Danijela Trifunović Zamaklar |
| 10:30-10:45 |
Marcus Hacker, Vienna |
Artificial Intelligence in nuclear medicine |
| 10:45-11:00 |
Marko Grahovac, Vienna |
AI algorithms in the multimodal imaging |
| 11:00-11:15 |
Danijela Trifunovic Zamaklar, Belgrade |
Artificial intelligence in echocardiogaphy |
| 11:15-11:25 |
Discussion |
|
| 3. REVASCULARIZATION: IMPORTANCE OF ISCHEMIA AND VIABILITY ASSESSMENT |
|
Chairpersons: Goran Stanković, Vojislav Giga |
| 11:30-11:45 |
Goran Stanković, Belgrade |
Importance od functional tests: interventional cardiologist view |
| 11:45-12:00 |
Pushan Baradwaj, Singapure |
SPECT in myocardial viability assessment |
| 12:00-12:15 |
Vojislav Giga, Belgrade |
Noninvasive assessment of CAD: is there a method of chioice? |
| 12:15-12:30 |
Radosav Vidaković, Belgrade |
Assessment of anatomy and function in coronary artery disease – role of CT and MRI |
| 12:30-12:40 |
Discussion |
|
| OPENING CEREMONY |
| 13:00-13:30 |
Dragana Šobić Šaranović,Belgrade |
Welcome, Cardiovascular nuclear medicine in the era of multimodality imaging |
|
Vera Artiko, Belgrade |
The role of Center of Nuclear Medicine, CCS in cardiovascular nuclear medicine |
|
Dean/Vise Dean |
Appointment of Visiting professor |
| 13:30-13:45 |
Diana Paez, IAEA |
Reducing Disparities in Access to Healthcare |
| WELCOME RECEPTION |
| 13:45-14:30 |
|
|
| 4. QUANTIFICATION OF CORONARY FLOW AND ISCHEMIA: IS IT IMPORTANT? |
|
Chairpersons: Branko Beleslin, Sabina Dizdarević |
| 14:30-14:45 |
Raffaele Giubbini, Brescia |
Measuring myocardial blood flow in the era of multimodality imaging |
| 14:45-15:00 |
Branko Beleslin, Belgrade |
Complex relation between invasive flow evaluation and ischemia! How to define myocardial ischemia in 2020? |
| 15:00-15:15 |
Ana Djordjević Dikić, Belgrade |
Diagnosis and risk stratification of coronary microvascular disease: Role of stress testing and noninvasive imaging |
| 15:15-15:30 |
Sabina Dizdarević, Brighton |
Role of gated Myocardial perfusion in pre operative risk assessment prior to AAA repair |
| 15:30-15:40 |
Discussion |
|
| 5. CARDIOVASCULAR INFECTION AND INFLAMMATION |
|
Chairpersons: Raluca Mititelu, Isidora Grozdić Milojević |
| 15:45-16:00 |
Sobhan Vinjamuri, Liverpool |
Incidental cardiac uptake on Ga68 DOTA scans. What does it mean? |
| 16:00-16:15 |
Jovica Šaponjski, Belgrade |
Role of MSCT in vasculitis |
| 16:15-16:30 |
Isidora Grozdic Milojevic, Belgrade |
The role of FDG PET/CT in cardiac sarcoidosis |
| 16:30-16:45 |
Raluca Mititelu, Bucharest |
The role of PET/CT in endocarditis |
| 16:45-17:00 |
Vasilios Prasopoulos, Athens |
The role of FDG PET/CT in the investigation of clinical suspicious of vasculitis |
| 17:00-17:10 |
Discussion |
|
| FRIDAY, OCTOBER 2, 2020 |
| 09:00-12:00 |
Registration of participants |
|
| 6. CARDIO-ONCOLOGY AND CARDIO-NEUROLOGY: IMPORTANCE IN CLINICAL PRACTICE |
|
Chairpersons: Branislava Ivanović, Snežana Šušnjar |
| 09:00-09:15 |
Branislava Ivanović, Belgrade |
Cardio-oncology:The mirror has two faces |
| 09:15-09:30 |
Snežana Šušnjar, Belgrade |
Why oncologists need cardiologists? |
| 09:30-09:45 |
Jelena Petrović, Dragana Šobić Šaranović, Belgrade |
MUGA scan in cardiac toxicity |
| 09:45-10:00 |
Maria Koutelu, Athens |
Cardiac neurotransmission imaging in heart diseases |
| 10:00-10:15 |
Milica Stojijkovic,Leposava Brajković, Dragana Šobić Šaranović, Belgrade |
Cardiac neurotransmission imaging in neurological disorders: eight years of experience Center of Nuclear Medicine, CCS |
| 10:15-10:25 |
Discussion |
|
| 7. CHRONIC CORONARY SYNDROME AND NUCLEAR MEDICINE |
|
Chairpersons: Nebojša Kozarević, Branislav Baškot |
| 10:30-10:45 |
Siniša Stanković, Banja Luka |
SPECT MPI in Diabetes type 2 patients: expirience in Banja Luka |
| 10:45-11:00 |
Jasna Mihailovic, Novi Sad |
Myocardial pefusion imaging in low risk patients for coronary artery disease with symptoms |
| 11:00-11:15 |
Amela Begić, Sarajevo |
Myocardial perfusion imaging in detection of ischemia: expirience in Sarajevo |
| 11:15-11:30 |
Branislav Baškot, Belgrade |
SPECT MPI in chronic coronary syndrome: expiriencein private practice |
| 11:30-11:45 |
Nebojša Kozarević, Belgrade |
SPECT MPI in microvascular disease |
| 11:45-12:00 |
Miloš Stević, Niš |
Myocardial perfusion imaging in detection of ischemia: expirience in Niš |
| 12:00-12:15 |
Katarina Nikoletic, Drummen |
Nuclear cardiology in Norway |
| 12:15-12:25 |
Discussion |
|
| 12:30-13:00 |
Coffee break |
|
| 8. POSTER WALK |
|
Chairpersons: Miloš Stević, Strahinja Odalović |
| 13:00-14:00 |
|
|
| 9.POSTER PRESENTATIONS OF TECHNOLOGISTS IN NUCLEAR MEDICINE |
|
Chairpersons: Tatjana Krkalović, Zorica Obradović |
| 14:00-15:00 |
|
|